Cardiol Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	229	130	151	72	44	142
Market Cap Growth	87.53%	-13.65%	110.34%	63.29%	-69.05%	55.49%
Enterprise Value	202	119	135	31	-21	113
Last Close Price	1.99	1.31	1.85	1.10	0.69	2.33
Forward PE	-	252.00	252.00	252.00	252.00	-
PS Ratio	-	-	-	-	-	1803.25
PB Ratio	9.48	7.29	6.11	2.54	0.84	1.86
P/TBV Ratio	9.48	7.29	6.11	2.56	0.85	1.87
EV/Sales Ratio	-	-	-	-	-	1441.08
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-1.14	-1.19	-1.23	-1.23	-1.14	-1.10
Net Debt / EBITDA Ratio	0.78	0.62	0.76	1.18	1.44	2.18
Net Debt / FCF Ratio	1.14	0.89	1.21	1.38	2.18	3.56
Asset Turnover	-	-	-	-	-	0.00
Quick Ratio	3.93	3.83	4.41	4.25	6.12	7.29
Current Ratio	4.39	4.16	4.52	4.36	6.27	7.54
Return on Equity (ROE)	-173.96%	-158.75%	-138.47%	-69.93%	-48.16%	-70.69%
Return on Assets (ROA)	-78.25%	-77.31%	-73.43%	-37.71%	-34.47%	-46.58%
Return on Capital Employed (ROCE)	-146.60%	-191.00%	-162.10%	-104.90%	-79.20%	-50.70%
Earnings Yield	-15.85%	-25.94%	-24.30%	-39.19%	-70.37%	-22.28%
FCF Yield	-10.58%	-18.32%	-16.61%	-35.17%	-62.10%	-16.58%
Buyback Yield / Dilution	-24.11%	-21.55%	-11.02%	-3.13%	-44.61%	-44.77%